| Literature DB >> 27594995 |
Suman B Koganti1, Ravikanth Kongara1, Sateesh Boddepalli1, Naushad Shaik Mohammad2, Venumadhav Thumma1, Bheerappa Nagari1, R A Sastry1.
Abstract
INTRODUCTION: Although surgery is the preferred treatment for grade III&IV pancreatic trauma, there is a growing movement for non-operative management. in blunt pancreatic trauma. Very few studies compare operative versus non-operative management in adult patients.Entities:
Keywords: AAST: American association for the surgery of trauma; ISGPF: International study group of pancreatic fistula; NOM: non-operative management
Year: 2016 PMID: 27594995 PMCID: PMC4995476 DOI: 10.1016/j.amsu.2016.08.003
Source DB: PubMed Journal: Ann Med Surg (Lond) ISSN: 2049-0801
Summary of all blunt pancreatic trauma patients according to different grades.
| Total | Operated | |
|---|---|---|
| Grade 1 | 16 | 2/16 |
| Grade2 | 17 | 3/17 |
| Grade 3 | 20 | 14/20 |
| Grade 4 | 14 | 10/14 |
| Grade 5 | 5 | 5/5 |
Fig. 1CT scan of a patient with grade IV pancreatic trauma complicated by necrotizing pancreatitis with colonic perforation. Patient had open necrosectomy on day 19 following trauma, closed external drainage along with temporary colostomy which was reversed after three months.
Clinical characteristics of operative and non-operative groups.
| Operative MX (16) | Non-operative (10) | P value | |
|---|---|---|---|
| Age (mean) | 43 (19–61) | 39 (20–72) | 0.095 |
| Sex (M/F) | 11/5 | 9/1 | 0.086 |
| ASA class III and above | 2 | 2 | 0.103 |
| 6.8 (3–12) | 2.2 (1–8) | 0.048 | |
| 0.0031 | |||
| Liver | 2 | 1 | |
| Spleen | 7 | 2 | |
| Duodenal | 2 | 1 | |
| Colonic | 1 | 0 | |
| Other (MSK) | 6 | 4 | |
| Grade III | 12 | 6 | 0.083 |
| Grade IV | 4 | 4 | |
| 0.001 | |||
| Respiratory | 12 | 3 | |
| Renal | 4 | 1 | |
| Cardio-vascular | 10 | 0 | |
| Pancreatitis | 8 | 2 | 0.078 |
| No of days of octreotide use | 96 (54–116) | 102 (84–186) | 0.068 |
| 0.001 | |||
| Abdominal abscess | 3/16 | 6/10 | |
| Hemorrhage | 1/16 | 2/10 | |
| Pancreatic fistula | 1/16 | 3/10 | |
| Necrosis | 2/16 | 3/10 | |
| 2/16 | 8/10 | 0.003 |
Nonparametric test; X2/Fischer's exact, Mann Whitney U test, p value of <0.05 is significant which is indicated in bold.
Regression analysis of factors predicting successful NOM of grade III/IV pancreatic trauma.
| Univariate analysis | Multivariate analysis | |||
|---|---|---|---|---|
| 0R (95% CI) | P value | OR (95% CI) | P value | |
| Age | 0.92 (0.77–1.11) | 0.360 | 1.10 (0.71–1.71) | 0.688 |
| Sex | 0.95 (0.77–1.16) | 0.592 | 1.22 (0.66–2.25) | 0.532 |
| ASA class > III | 1.09 (0.80–1.49) | 0.578 | 1.04 (0.84–1.29) | 0.710 |
| 2.24 (1.78–2.83) | 0.0001 | 0.87 (0.32–2.36) | 0.781 | |
| 1.54 (1.15–2.06) | 0.003 | 1.48 (0.20–11.09) | 0.701 | |
| 1.66 (1.37–2.00) | 0.0001 | 1.04 (1.01–1.08) | 0.018 | |
| 0.45 (0.32–0.64) | 0.005 | 0.57 (0.35–0.94) | 0.026 | |
| Blood transfusion | 1.19 (0.93–1.53) | 0.161 | 1.09 (0.80–1.49) | 0.572 |
| 1.95 (1.28–2.97) | 0.002 | 1.63 (1.16–2.30) | 0.005 | |
| Octreotide use | 1.43 (0.82–2.49) | 0.214 | 1.22 (0.66–2.25) | 0.536 |
| 1.62 (1.36–1.95) | 0.013 | 1.04 (0.84–1.29) | 0.710 | |
| 1.58 (1.39–1.80) | 0.00011 | 1.02 (0.99–1.04) | 0.153 | |
NOM (Non-operative management).